Professional Documents
Culture Documents
Case Report
Presented by :
Nurani Widianti, dr.
Consultants :
Prof. Mohammad Sjaifullah Noer, dr., Sp.A(K)
INTRODUCTION
CASE REPORT
Figure 2. Weight for age birth to 5 years old WHO growth chart for boys
revealed severely underweight
7
Figure 3. Length for age birth to 5 years old WHO growth chart for boys
revealed severely stunted
Figure 4. Weight for length birth to 5 years old WHO growth chart for boys
revealed severely wasted
8
Figure 5. Head circumference for age birth to 5 years old WHO growth chart
revealed microcephaly
He was unable to eat by himself, unable to wear and put off his
clothes, and unable to build up blocks. He was able to sit independently, stand
up with hold on, but unable to walk. He just could say a word unclearly and was
classified as global developmental delay.
F F
F
F F
F
F
F
F. F
F F
Figure 13. Head CT scan without contrast showed within normal limit
14
DISCUSSION
In this case, patient came to Orthopaedic Outpatient Clinic with
chief complaint inability to walk and the pelvis x-ray showed the dysplasia of
the hip. Developmental dysplasia of the hip (DDH) is οne of the most common
skeletal deformities. DDH is a complex syndrome that encompasses a broad
spectrum of anatomical malformations of the growing hip, sharing in common
the abnormal relationship between the femoral head and acetabulum.
Deformities in the shape, size and orientation of the femoral head, acetabulum
or both are variably expressed. The hips that are grossly deformed, either
subluxated or dislocated, are easily recognized at birth and are managed
accordingly. However, some subtle characteristics of dysplastic hips, such as
shallowness and underdevelopment of the acetabulum, may escape diagnosis. 6
In this case, the patient planned for hip surgery but the impaired
renal function was found with multicystic renal bilateral, mild bilateral
hydronephrosis, and chronic kidney disease stage V that revealed
nephronophthisis. Nephronophthisis (NPHP) is a clinical condition caused by a
group of autosomal recessive cystic kidney disorders that typically progresses
to end-stage renal disease (ESRD). It is caused by mutations in a large number
of genes that encode proteins involved in the function of primary cilia, basal
bodies, and centrosomes, resulting in renal disease and extrarenal
manifestations. 7
According to mutations in a large number of genes that encode
proteins involved in the function of primary cilia, cilia are hair-like organelles
projecting from the surface of cells and can be divided into two main subgroups:
motile cilia, occurring in bundles of hundreds and single non-motile (primary)
cilia. While the presence of motile cilia is restricted to highly specialized tissues
such as the respiratory tract, brain ventricles, reproductive tract and embryonic
node in mammals, primary cilia can be found on nearly every cell throughout
the organism. 8
16
syndrome. 4 Due to the mutation of IFT genes, the differential diagnosis of the
nephronopthisis condition are Joubert syndrome and related disorder (JSRD),
polycystic kidney disease (PKD) and Bardet-Biedl syndrome (BBS). 5 In PKD,
characterized by formation of fluid-filled cysts caused by mutation in PKD 1
and PKD2 that leads to cystogenesis.6 In JSRD it differs by the molar tooth sign
or neural tube defects (posterior omphalocele) condition in cerebellum. 4
All known genes associated with cranioectodermal dysplasia encode
proteins of the intraflagellar transport (IFT). IFT is a highly evolutionary
conserved process which plays an essential role in the assembly, maintenance
and function of cilia). Cilia are microtubule-based structures extending from the
surface of almost all cell types of the human body. Those structures function
either as a motor providing motility or as a sensor that detects environmental
and physiological signals. Cilia play a crucial role during embryogenesis, as
well as during the postnatal life, where they are transducing signals and
maintaining several signaling pathways, such as the Hedgehog (Hh), Wnt,
platelet-derived growth factor receptor (PDGFR) and fibroblast growth factor
(FGF) pathways. Defects in ciliary proteins, cilia structure and function lead to
a broad range of phenotypes collectively known as ciliopathies. 4
Ciliary chondrodysplasias represent a group of phenotypically and
genetically related disorders inherited in an autosomal recessive fashion
including short-rib polydactyly syndromes, which are also referred to as short-
rib thoracic dystrophy, Jeune asphyxiating thoracic dystrophy or Jeune
syndrome, Mainzer-Saldino syndrome, Sensenbrenner syndrome or cranio-
ectodermal dysplasia, and Ellis-van Creveld syndrome. 10
Cranioectodermal dysplasia (CED) is part of a spectrum of disorders
caused by disruption of the cilium, an organelle of the cell that appears and
functions as an antenna. These disorders, collectively referred to as ciliopathies,
display marked phenotypic overlap. Typical clinical features of ciliopathies are
renal cystic disease, retinal dystrophy, shortening of ribs, phalanges and long
bones, polydactyly, hepatic fibrosis, and developmental delay. 2
19
Always,
Mildly
Mainzer- mainly Mild thorax
shortened Cholestasis
Saldino Autosomal NPHP- Always Single Not phenotype, usually no IFT140, IFT172
ribs, cone and hepatic -
syndrome recessive like, cases described cardiorespiratory
shaped fibrosis
(MZSDS) rarely lethality
epiphyses
cystic
20
Facial dysmorphism
with
telecanthus/epicanthus
Mildly , high forehead, broad
Inconsistent
shortened nasal bridge, low-set
hepatic
ribs, brachy- Very prominent ears, thin
CED cysts and
Autosomal dactyly, often, and sparse growing
(Sensenbre fibrosis, Sometim Usually IFT122, WDR19,
recessive craniosynos- mainly Sometimes - hair, nail dysplasia,
ner ductal plate es not IFT43, WDR35
tosis leading NPHP teeth abnormalities,
syndrome) malforma-
to dolicho- like heart defects; usually
tion
cephalus mild thorax phenotype
and no
cardiorespiratory
lethality
Polycystic
liver
disease,
multiple
Caroli Autosomal
- - - simple - - - - PKHD1
disease recessive
biliary
hepatic
cyst, biliary
hamartomas
in 80.0% (4/5), 25.0% (1/4), 50% (1/2), and 50% (1/2) of patients with WDR35,
5
IFT122, C14ORF179/IFT43, and WDR19 mutations, respectively.
Characteristic facial features often seen: Frontal bossing, bitemporal narrowing,
and a tall forehead, low-set, simple and/or posteriorly rotated ears, telecanthus,
epicanthal folds, and/or down/upslanting palpebral fissures, full cheeks,
micrognathia, everted lower lip, anteverted nares. 3
Individuals w/a
Affected
Molecularly
Individuals
Frequency Features Confirmed
Reported in
Diagnosis
Detail (N=33)
(N=15)
Joint laxity 15 12
Liver disease
(hepatic fibrosis,
14 9
cirrhosis, and/or
hepatomegaly)
Syndactyly 13 5
Abnormal nails 12 4
Less
Developmental
common 11 5
delay
(25%-50%)
Heart defect 9 4
Skin laxity 11 9
Recurrent lung
8 4
infections
Polydactyly 6 5
Bilateral inguinal
6 6
hernias
Proportion of
Gene / CED Attributed
Variants
Locus to Pathogenic Test Method
Detected
Name Variants in This
Gene
IFT122 / Sequence
4/41 Sequence analysis
CED 1 variants
Sequence
Sequence analysis
variants
WDR35 / Unknown; no
9/41
CED 2 Deletion/duplication deletions/
analysis duplications
reported
IFT43 / Sequence
2/41 Sequence analysis
CED 3 variants
WDR19 / Sequence
2/41 Sequence analysis
CED 4 variants
Unknown 23/41 NA NA
mutation occurs in two genes, IFT122 and WRD35 gene. Both genes encode
proteins that are part of the IFT A (IFT-A) complex which is required for ciliary
assembly, disassembly, and homeostasis. 4 A study performed in a Morrocan
descent family showed homozygous mutation in the initiation codon in
C14ORF179 which encodes a member of IFT-A particle (IFT43). The identified
genetic defect results shortened protein and consisted with disruption of IFT-A
protein complex. These mutations characterized as Sensenbrenner syndrome.
WDR35 is the only gene causing developmental delay, although not
in all cases. Renal insufficiency often develops in infancy or early childhood in
children with biallelic mutations in IFT122, WDR35, IFT43, or WDR19. 5 An
in-frame WDR35 homozygous 2,847-bp deletion spanning exon 5 was
identified in a family with short rib-polydactyly syndrome type V. Compound
heterozygous changes (p.Arg545Ter and p.Trp261Arg) were identified in
another family with short rib-polydactyly syndrome type V. WDR35 comprises
28 exons. This gene is expressed in at least two WDR35 splice variants. The
largest transcript encodes an 1,181-amino-acid protein. 21
The majority of variants associated with CED have been identified
in WDR35; i.e., six of the 11 families with CED with a molecular diagnosis had
pathogenic variants in this gene. The WDR35 pathogenic variants include seven
missense variants, one splice site variant, one stop variant, and a single-bp
deletion, scattered throughout the gene. 22
WDR35 encodes one of the six members of IFT-A protein complex
that regulates retrograde trafficking in the cilium. Defects in WDR35 affect the
process of intraflagellar transport. Immunocytochemistry revealed
accumulations of IFT-B proteins (IFT57 and IFT88) in ciliary tips of cells
derived from an individual with CED with biallelic WDR35 pathogenic
variants. Such accumulations represent a typical "IFT-A" defect, and have
previously been observed in ciliated cells of many different species, including
C. elegans, C. reinhardtii, D. melanogaster, T. brucei, and M. musculus,
wherein IFT-A orthologues were knocked out. A Wdr35 knockout mouse (yeti)
was recently published. Homozygotes for a splice acceptor pathogenic variant
31
and renal) also important to rule out the cystic condition, it is important because
cyst can leads to hepatic and renal failure. 19
As needed, surgery to correct sagittal craniosynostosis (usually age
<1 year) and/or polydactyly of the hands and feet. Routine treatment of inguinal
and umbilical hernias, nephronophthisis, liver disease, and/or cardiac
anomalies. For those with developmental delay: speech and physical therapy,
and appropriate educational programs. For those with progressive visual
impairment: low vision aids and appropriate educational programs. Human
growth hormone therapy should be considered in those who meet standard
treatment criteria. 3
Treatment includes the following: Surgery for correcting
craniosynostosis (usually in first year of life), correction of polydactyly
(optional), orthopaedic care as required (e.g., for hip dysplasia), growth
hormone treatment to stimulate growth when standard criteria for this treatment
are met. Growth hormone should only be prescribed to children with severe
growth retardation in whom the therapy is expected to be successful. Dental
care is important due to detection and intervention of structural tooth
abnormalities and/or oligodontia may limit aesthetic, functional, and
psychological issues. Standard treatment for renal and liver abnormalities.
While liver transplantation is a treatment option in advanced stages, it has only
been proposed once for an individual with CED. For those with progressive
visual impairment, low vision aids and appropriate educational programs.
Mechanical ventilation as required in newborn to treat respiratory insufficiency
due to pulmonary hypoplasia. 12
For those with developmental delay, speech therapy and physical
therapy to improve motor skills and appropriate educational programs. Surgical
intervention as required for inguinal/umbilical hernias 3
35
osmolarity testing in morning urine, urine collection assays to test for polyuria,
measurement of blood pressure, determination of serum creatinine and blood
urea concentrations to establish renal function, and periodic renal ultrasound
examination to establish kidney size and presence of cysts. Periodic
measurement of liver enzymes starting at the time of diagnosis.
Annual ophthalmologic examinations starting at age four years.
Electroretinography (ERG) and fundoscopy can be performed at an earlier age
if it is evident that vision is reduced. Evaluation for respiratory infection (with
x-rays and sputum analysis) when clinical findings suggest pneumonia. In those
with structural heart defects, periodic monitoring of cardiac function including
auscultation, ECG, and echocardiography. 3
Carrier testing for at-risk relatives and prenatal testing for
pregnancies at increased risk are possible if the pathogenic variants in the family
have been identified. Second- trimester ultrasound examination may detect
3
renal cysts, shortening of the limbs, and/or polydactyly. If the pathogenic
variants are known in a family, it is appropriate to clarify the genetic status of
at-risk infants to allow early diagnosis and appropriate management and
surveillance, particularly for respiratory complications, renal and liver disease,
and visual impairment. If the pathogenic variants are not known in a family, the
following is recommended for at-risk children: In the newborn period: physical
examination by a pediatrician, and consultation with a clinical geneticist as
determined by the clinical findings. Age 0-3 months: kidney and liver
evaluation, including ultrasound examination and measurement of blood
pressure, serum creatinine concentration, and liver enzymes. At six-month
intervals: repeat the kidney and liver evaluations. 15
Parents should be alerted to the signs of CED and advised to contact
their child's health care provider if suspicious symptoms, such as polydipsia
and/or jaundice, appear. 3 Parents of a proband: The parents of an affected child
are obligate heterozygotes (i.e., carriers of one mutated allele), heterozygotes
(carriers) are asymptomatic. In such cases, one parent may not be a carrier.
Thus, documentation of carrier status in both parents is appropriate. 10
37
Renal and liver disease are the main contributors of morbidity and
mortality in patient with Sensenbrenner syndrome. 5 Morbidity is high in CED
and hospitalization may be frequent and/or long-term. Mortality rates are
unclear, although 7/33 of children with CED died before age seven years of
respiratory failure, heart failure, hypovolemic shock (as a result of
coagulopathy), or unknown causes. 3
38
SUMMARY
A case of clinical manifestations in a highly suspected patient with
Sensenbrenner syndrome has been reported. A, three year old boy was referred
to Pediatric Nephrology Outpatient Clinic of Dr. Soetomo Hospital with chief
complaint of impaired renal function. He was referred from Orthopaedic and
Traumatology Outpatient Clinic Department of Dr. Soetomo Hospital with the
diagnosis of dysplasia of the hip and he was planned for hip surgery. The only
complaint was inability to walk.
Physical examination presents facial dysmorphic features, bilateral
hernia inguinalis, malnutrition, and global developmental delay. Laboratory
examination resulted of glomerular filtration rate reduction that indicated
chronic kidney disease stage V. Renal ultrasonography showed multicystic
renal bilateral, mild bilateral hydronephrosis, and nephronophthisis. X-ray
examination showed dolichocephaly and dysplasia of the hip.
He was diagnosed by suspect Sensenbrenner syndrome with
chronic kidney diseases stage V, multicystic renal bilateral and mild
hydronephrosis bilateral, nephronophthisis, developmental dysplasia of hip,
bilateral hernia inguinalis, and global developmental delay. He was planned for
genetic PCR to establish the diagnosis, continuous ambulatory peritoneal
dialysis, hip surgery, consulted to pediatric surgeon, and consulted to growth
and developmental division. He got treatment sodium bicarbonate for three
times a day, vitamin B12 for three times a day, folic acid for three times a day,
and fluid restriction maximal 800 ml per day.
For all Sensenbrenner patients, renal and liver disease are the main
contributors of morbidity and mortality. Morbidity is high in cranioectodermal
dysplasia and hospitalization may be frequent and long-term.
39
REFERENCES
1. Devlin LA, Sayer JA. Renal ciliopathies. Curr Opin Genet Dev 2019;49-60
2. Braun DA, Hildebrandt F. Ciliopathies. 2016; 48: 1-20
3. Arts H, Knoers N, Adam MP, Ardinger HH, Pagon RA et al.
Cranioectodermal Dysplasia. US National Library of Medicine. University
of Washington, Seattle; 2018. 1–27
4. Walczak-sztulpa J. Clinical and molecular genetic characterization of a male
patient with Sensenbrenner syndrome ( cranioectodermal dysplasia ) and
biallelic WDR35 mutations. 2018; 20-27
5. Lin AE, Traum AZ, Sahai I, Keppler-noreuil K, Kukolich MK, Adam MP,
et al. Sensenbrenner Syndrome ( Cranioectodermal Dysplasia ): Clinical and
Molecular Analyses of 39 Patients Including Two New Patients Die. 2013
6. Zhu L qing, Su G hao, Dai J, Zhang W yan, Yin C hua, Zhang F yong, et al.
Whole genome sequencing of pairwise human subjects reveals DNA
mutations specific to developmental dysplasia of the hip. Genomics
2019;111(3):320–6
7. Hildebrandt F, Attanasio M, Otto E. Nephronophthisis: Disease mechanisms
of a ciliopathy. J Am Soc Nephrol. 2009;20(1):23–35
8. Hoefele J, Wolf MTF, O’Toole JF, Otto EA, Schultheiss U, Dêschenes G, et
al. Evidence of oligogenic inheritance in nephronophthisis. J Am Soc
Nephrol. 2007;18(10):2789–95
9. National Institute of Diabetes and Digestive and Kidney Diseaes. Treatment
for Kidney Failure in Children | NIDDK. 2014
10. Walczak-Sztulpa J, Eggenschwiler J, Osborn D, Brown DA, Emma F,
Klingenberg C, et al. Cranioectodermal Dysplasia, Sensenbrenner
Syndrome, Is a Ciliopathy Caused by Mutations in the IFT122 Gene. Am J
Hum Genet. 2010;86(6):949–56
11. Obikane K, Nakashima T, Watarai Y, Morita K, Cho K, Tonoki H, et al.
Renal failure due to tubulointerstitial nephropathy in an infant with
40